Altria Group, Inc. Announces Retirement of Director Nabil Y. Sakkab From Board of Directors
"Nabil's contributions have significantly benefited Altria over the past 15 years," said Kathryn McQuade, Altria’s independent Chair of the Board. "We thank him for his long and distinguished service and wish him the very best upon his retirement."
Dr. Sakkab is Chair of the Innovation Committee and is a member of the Executive, Finance, and Nominating, Corporate Governance and Social Responsibility Committees. Dr. Sakkab held a variety of positions at The Procter & Gamble Company beginning in 1974. He retired in November 2007 as Senior Vice President, Corporate Research and Development. He is a director of several privately held companies. He previously served as a director of Deinove (Euronext Growth Paris: ALDEI) from 2010 to April 2016, Givaudan SA (SWX: GIVN) from 2008 to March 2015 and Pharnext (Euronext Growth Paris: ALPHA) from 2012 to July 2020.
Altria’s Profile
We have a leading portfolio of tobacco products for
Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris
Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the
Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company.
The brand portfolios of our operating companies include Marlboro®, Black & Mild®,
Learn more about Altria at www.altria.com and follow us on X (formerly known as Twitter), Facebook and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231025901175/en/
Investor Relations
Altria Client Services
(804) 484-8222
Media Relations
Altria Client Services
(804) 484-8897
Source: Altria Group, Inc.